What medication can be added to a patient already taking venlafaxine extended‑release 150 mg daily for worsening depression?

Augmentation Strategies for Treatment-Resistant Depression on Venlafaxine ER 150mg

For a patient with worsening depression on venlafaxine ER 150mg daily, the most evidence-based approach is to first optimize the venlafaxine dose to 225mg daily (the therapeutic range for depression), and if inadequate response persists, add either bupropion SR or mirtazapine as augmentation therapy. 1

Initial Step: Optimize Current Therapy

Before adding another medication, ensure the venlafaxine dose is adequate:

• Increase venlafaxine ER to 225mg daily if tolerated, as the therapeutic dosing range is 75-225mg/day for depression 2
• Allow 4-6 weeks at the optimized dose for adequate trial 2
• Monitor blood pressure regularly, as venlafaxine can cause dose-related hypertension 3

Evidence-Based Augmentation Options

If depression persists after optimizing venlafaxine, the following augmentation strategies have demonstrated efficacy:

First-Line Augmentation: Bupropion SR

• Start bupropion SR 100-150mg daily, increase to 150-450mg daily as tolerated 4, 5
• This combination showed equivalent efficacy to other augmentation strategies in the STAR*D trial 1
• Bupropion has activating properties and may improve energy levels, making it particularly useful if apathy or low energy predominate 5
• Lower discontinuation rates due to adverse effects compared to buspirone augmentation (12.5% vs 20.6%) 1
• Avoid in patients with seizure disorders or significant agitation 5
• The venlafaxine-bupropion combination has demonstrated synergistic effects in treatment-resistant depression 6

Alternative First-Line: Mirtazapine

• Start mirtazapine 7.5-15mg at bedtime, titrate to 30mg as needed 5
• The venlafaxine-mirtazapine combination showed 50% response rates at 8 weeks and 56% at 6 months in patients with persistent depressive illness 7
• Particularly useful if insomnia, poor appetite, or weight loss are prominent 5
• Most common side effects are sedation (19%) and weight gain (19%) 7
• Well-tolerated combination with no serious adverse effects reported 7

Second-Line Augmentation: SSRI Addition

• Consider adding sertraline, citalopram, or paroxetine to venlafaxine in partial responders 8
• Case reports demonstrate improvement when SSRIs are added to high-dose venlafaxine 8
• Exercise caution due to serotonin syndrome risk when combining serotonergic agents 9, 3
• Start at low doses and titrate slowly, monitoring closely in the first 24-48 hours after any dose change 9

Critical Safety Considerations

Serotonin Syndrome Risk

When combining venlafaxine with other serotonergic medications:

• Monitor for mental status changes, neuromuscular hyperactivity, and autonomic instability 9
• Symptoms typically arise within 24-48 hours of combining medications 9
• Avoid MAOIs entirely - do not use within 14 days of venlafaxine 3
• Use caution with tramadol, triptans, and other serotonergic agents 3

Drug Interactions

• Venlafaxine is metabolized by CYP2D6 and CYP3A4 3
• Bupropion and SSRIs may inhibit CYP2D6, potentially increasing venlafaxine levels 3
• Monitor for increased side effects when combining medications 3

Monitoring Parameters

• Blood pressure monitoring is essential, as venlafaxine causes dose-related increases 3
• Check cholesterol levels periodically 3
• Monitor for bleeding risk if patient takes NSAIDs, aspirin, or anticoagulants 3

Alternative Strategies if Augmentation Fails

If augmentation strategies prove inadequate after 4-6 weeks at therapeutic doses:

• Consider switching to a different antidepressant class rather than continuing combination therapy 1
• The STAR*D trial found no significant differences between switching strategies (to bupropion SR, sertraline, or another SNRI) 1
• Referral to psychiatry for consideration of other options including atypical antipsychotics (aripiprazole showed higher remission rates than bupropion in one trial) 1

Common Pitfalls to Avoid

• Do not add medications before optimizing the venlafaxine dose to the therapeutic range of 225mg daily 2
• Do not abruptly discontinue venlafaxine - taper over 10-14 days to avoid withdrawal syndrome (anxiety, dizziness, electric shock sensations, nausea) 5, 3
• Do not combine multiple serotonergic agents without careful monitoring for serotonin syndrome 9, 3
• Do not use bupropion in patients with eating disorders or seizure history due to increased seizure risk 5